Author: Daniel snow
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca.The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead of the RSV season that typically kicks off around fall and winter and lasts through the spring. Merck said in a release that it expects orders for the shot to begin in July, with shipments delivered before the virus starts to spread widely.The approval gives doctors…
Uncertainty about the U.S. economy, prices and job security is making it harder for people to make financial decisions. Here’s help. Source link
A new study by PwC found that AI adoption is driving job creation and increasing productivity. But not every company is reaping the benefits. Source link
A sign in front of the entrance of the Security Administration’s main campus on March 19, 2025 in Woodlawn, Maryland. Kayla Bartkowski | Getty ImagesThe Supreme Court on Friday granted the Department of Government Efficiency access to Social Security Administration data that includes sensitive personal information of millions of Americans.The decision comes as the federal government sought a stay, or temporary suspension, after a federal judge blocked DOGE’s access to that data in April. The nation’s highest court granted an emergency application from the Trump administration to lift that injunction; the case is expected to proceed in lower courts.In its decision,…
Going all in on AI may sound great in the C-suite, but your customers may feel very differently. Source link
Readers respond to the Trump administration’s deployment of National Guard troops to quell protests in Los Angeles. Source link
Paraguay president's X account likely hacked in Bitcoin scheme Source link
Polls show more support for the president’s immigration policy than his policies on the economy or inflation. Source link
As traders brace for a fresh round of U.S. inflation data this week, a new twist is developing in the way some are thinking about the likely impact of tariffs and the path that major asset classes could take from here. Source link
Nucleus Genomics founder Kian Sadeghi is making bold claims about his company’s genetic testing technology. Source link